Invesco Ltd. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$76,850
-38.1%
45,473
+1.8%
0.00%
Q2 2023$124,213
+61.6%
44,681
+5.8%
0.00%
Q1 2023$76,860
-95.4%
42,231
-87.3%
0.00%
Q4 2022$1,687,580
+715.3%
332,856
+697.3%
0.00%
Q3 2022$207,000
+42.8%
41,746
+6.9%
0.00%
Q2 2022$145,000
-27.5%
39,052
+9.4%
0.00%
Q1 2022$200,000
-1.0%
35,708
+7.5%
0.00%
Q4 2021$202,000
-49.4%
33,212
-19.0%
0.00%
Q3 2021$399,000
-30.6%
40,997
+1.8%
0.00%
Q2 2021$575,000
+126.4%
40,257
+275.5%
0.00%
Q1 2021$254,00010,7220.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders